Extracorporeal Membrane Oxygenation Support in Children With Hematologic Malignancies in Sweden.


Journal

Journal of pediatric hematology/oncology
ISSN: 1536-3678
Titre abrégé: J Pediatr Hematol Oncol
Pays: United States
ID NLM: 9505928

Informations de publication

Date de publication:
01 03 2021
Historique:
received: 30 09 2019
accepted: 23 03 2020
pubmed: 15 4 2020
medline: 7 4 2021
entrez: 15 4 2020
Statut: ppublish

Résumé

Extracorporeal membrane oxygenation (ECMO) is used in severe respiratory and/or circulatory failure when conventional critical care fails. Studies on patients with hematologic malignancies on ECMO have shown contradictory results; immunosuppression and coagulopathy are relative contraindications to ECMO. This nationwide Swedish retrospective chart review identified 958 children with hematologic malignancies of whom 12 (1.3%) required ECMO support. Eight patients survived ECMO, 7 the total intensive care period, and 6 survived the underlying malignancy. ECMO may be considered in children with hematologic malignancy. Short-term and long-term survival, in this limited group, was similar to that of children on ECMO at large.

Sections du résumé

BACKGROUND
Extracorporeal membrane oxygenation (ECMO) is used in severe respiratory and/or circulatory failure when conventional critical care fails. Studies on patients with hematologic malignancies on ECMO have shown contradictory results; immunosuppression and coagulopathy are relative contraindications to ECMO.
OBSERVATIONS
This nationwide Swedish retrospective chart review identified 958 children with hematologic malignancies of whom 12 (1.3%) required ECMO support. Eight patients survived ECMO, 7 the total intensive care period, and 6 survived the underlying malignancy.
CONCLUSIONS
ECMO may be considered in children with hematologic malignancy. Short-term and long-term survival, in this limited group, was similar to that of children on ECMO at large.

Identifiants

pubmed: 32287104
pii: 00043426-202103000-00041
doi: 10.1097/MPH.0000000000001808
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e272-e275

Informations de copyright

Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

Butt W, MacLaren G. Extracorporeal membrane oxygenation. F1000Prime Rep. 2013;5:55.
Jenks CL, Raman L, Dalton HJ. Pediatric extracorporeal membrane oxygenation. Crit Care Clin. 2017;33:825–841.
Coleman RD, Goldman J, Moffett B, et al. Extracorporeal membrane oxygenation mortality in high-risk populations: an analysis of the pediatric health information system database. ASAIO J. 2020;66:327–331.
Barbaro RP, Odetola FO, Kidwell KM, et al. Association of hospital-level volume of extracorporeal membrane oxygenation cases and mortality. Analysis of the extracorporeal life support organization registry. Am J Respir Crit Care Med. 2015;191:894–901.
Gupta M, Shanley TP, Moler FW. Extracorporeal life support for severe respiratory failure in children with immune compromised conditions. Pediatr Crit Care Med. 2008;9:380–385.
Kang HS, Rhee CK, Lee HY, et al. Clinical outcomes of extracorporeal membrane oxygenation support in patients with hematologic malignancies. Korean J Intern Med. 2015;30:478–488.
Frey TK, Chopra A, Lin RJ, et al. A child with anterior mediastinal mass supported with veno-arterial extracorporeal membrane oxygenation. Pediatr Crit Care Med. 2006;7:479–481.
Huang YL, Yang MC, Huang CH, et al. Rescue of cardiopulmonary collapse in anterior mediastinal tumor: case presentation and review of literature. Pediatr Emerg Care. 2010;26:296–298.
Huprikar NA, Peterson MR, DellaVolpe JD, et al. Salvage extracorporeal membrane oxygenation in induction-associated acute respiratory distress syndrome in acute leukemia patients: a case series. Int J Artif Organs. 2019;42:49–54.
Broman LM, Holzgraefe B, Palmer K, et al. The Stockholm experience: interhospital transports on extracorporeal membrane oxygenation. Crit Care. 2015;19:278.
Cortina G, Neu N, Kropshofer G, et al. Extracorporeal membrane oxygenation offers long-term survival in childhood leukemia and acute respiratory failure. Crit Care. 2018;22:222.
Carpenter JL, Yu YR, Cass DL, et al. Use of venovenous ECMO for neonatal and pediatric ECMO: a decade of experience at a tertiary children’s hospital. Pediatr Surg Int. 2018;34:263–268.

Auteurs

Susanna Ranta (S)

Childhood Cancer Research Unit, Department of Women's and Children's Health.
Astrid Lindgren Children's Hospital, Karolinska University Hospital.

Håkan Kalzén (H)

Department of Pediatric Perioperative Medicine and Intensive Care, ECMO, Karolinska University Hospital, Stockholm.
Department of Anaesthesia and Intensive Care, Karolinska Institutet at Danderyd Hospital (KIDS), Danderyd.

Anna Nilsson (A)

Childhood Cancer Research Unit, Department of Women's and Children's Health.
Astrid Lindgren Children's Hospital, Karolinska University Hospital.

Katarina von Schewelov (K)

Department of Pediatric Perioperative Medicine and Intensive Care, ECMO, Karolinska University Hospital, Stockholm.

Lars M Broman (LM)

Department of Physiology and Pharmacology, Karolinska Institutet.
Department of Pediatric Perioperative Medicine and Intensive Care, ECMO, Karolinska University Hospital, Stockholm.

Jonas Berner (J)

Department of Pediatric Perioperative Medicine and Intensive Care, ECMO, Karolinska University Hospital, Stockholm.

Urban Fläring (U)

Department of Physiology and Pharmacology, Karolinska Institutet.
Department of Pediatric Perioperative Medicine and Intensive Care, ECMO, Karolinska University Hospital, Stockholm.

Ulrika Norén-Nyström (U)

Department of Clinical Sciences, Pediatrics, Umeå University, Umeå.

Johan E Svahn (JE)

Department of Pediatric Oncology, Skåne University Hospital, Lund University, Lund.

Josefine Palle (J)

Department of Women's and Children's Health, Uppsala University.
Department of Pediatric Oncology, Uppsala University Hospital, Uppsala.

Lisa Törnudd (L)

Department of Pediatrics, Linköping University Hospital, Linköping.

Lene Karlsson (L)

Department of Pediatric Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden.

Karin Mellgren (K)

Department of Pediatrics, Linköping University Hospital, Linköping.

Jonas Abrahamsson (J)

Department of Pediatric Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden.

Arja Harila-Saari (A)

Department of Women's and Children's Health, Uppsala University.
Department of Pediatric Oncology, Uppsala University Hospital, Uppsala.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH